Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole

被引:56
作者
Garcia, JJ
Bolás, F
Torrado, JJ
机构
[1] Univ Complutense Madrid, Fac Farm, Dept Farmacia & Tecnol Farmaceut, E-28040 Madrid, Spain
[2] Univ Complutense Madrid, Fac Farm, Dept Parasitol, E-28040 Madrid, Spain
关键词
albendazole; bioavailability; activity; efficacy; cyclodextrin; pharmacokinetic;
D O I
10.1016/S0378-5173(02)00559-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The oral bioavailability and anthelmintic efficacy in mice of a new formulation of albendazole (ABZ) dissolved in a solution of hydroxypropyl-beta-cyclodextrin (HPCD) are compared with a conventional ABZ suspension of carboxymethylcellulose. Plasma concentrations of ABZ and albendazole sulphoxide (ABZ-SO), its active and main metabolite, were assayed by HPLC. The AUC(0-infinity) and C-max values obtained for both ABZ and ABZ-SO, after administration of the ABZ-HPCD solution were significantly higher (P < 0.01) than those obtained from the ABZ suspension. Although, the differences between the ABZ and ABZ-SO-T-max values were found not to be significant, regardless of the formulation. The anthelmintic activities against enteral (pre-adult) and parenteral (migrating and encysted larvae) stages of Trichinella spiralis were studied in mice. The ABZ solution was more efficient against pre-adult and encysted larvae than the ABZ suspension. The efficacy differences between both formulations against the migrating larvae, were found to be not significant (P < 0.05). For the migrating parasite stage, there was a linear correlation between the anthelmintic activity and pharmacokinetical parameters with respect to the ABZ-AUC(0-infinity) value. Meanwhile, for the muscular encysted parasite stage, better relationships were obtained for AUC(0-infinity) and C-max values from ABZ-SO, which had correlation coefficients of 0.996 and 0.987, respectively. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:351 / 358
页数:8
相关论文
共 22 条
[1]  
BENOIT E, 1992, AM J VET RES, V53, P1663
[2]   Preparation and characterization of albendazole β-cyclodextrin complexes [J].
Castillo, JA ;
Palomo-Canales, J ;
Garcia, JJ ;
Lastres, JL ;
Bolas, F ;
Torrado, JJ .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (12) :1241-1248
[3]   SPECIES-DIFFERENCES IN THE GENERATION OF THE CHIRAL SULFOXIDE METABOLITE OF ALBENDAZOLE IN SHEEP AND RATS [J].
DELATOUR, P ;
BENOIT, E ;
CAUDE, M ;
TAMBUTE, A .
CHIRALITY, 1990, 2 (03) :156-160
[4]   COMPARATIVE ENANTIOSELECTIVITY IN THE SULFOXIDATION OF ALBENDAZOLE IN MAN, DOGS AND RATS [J].
DELATOUR, P ;
BENOIT, E ;
BESSE, S ;
BOUKRAA, A .
XENOBIOTICA, 1991, 21 (02) :217-221
[5]   CHIRALITY OF THE SULFOXIDE METABOLITES OF FENBENDAZOLE AND ALBENDAZOLE IN SHEEP [J].
DELATOUR, P ;
BENOIT, E ;
GARNIER, F ;
BESSE, S .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1990, 13 (04) :361-366
[6]   CHIRAL BEHAVIOR OF THE METABOLITE ALBENDAZOLE SULFOXIDE IN SHEEP, GOATS AND CATTLE [J].
DELATOUR, P ;
GARNIER, F ;
BENOIT, E ;
CAUDE, I .
RESEARCH IN VETERINARY SCIENCE, 1991, 50 (02) :134-138
[7]  
DENHAM D A, 1970, Journal of Helminthology, V44, P357
[8]  
EVRARD B, 1998, 9 INT S CYCL SANT CO
[9]   Quantitative determination of albendazole and its main metabolites in plasma [J].
Garcia, JJ ;
Bolás-Fernández, F ;
Torrado, JJ .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1999, 723 (1-2) :265-271
[10]   Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes [J].
García-Rodriguez, JJ ;
Torrado, J ;
Bolás, F .
PARASITE, 2001, 8 (02) :S188-S190